Your browser doesn't support javascript.
loading
Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.
Chew, Kara W; Moser, Carlee; Daar, Eric S; Wohl, David A; Li, Jonathan Z; Coombs, Robert W; Ritz, Justin; Giganti, Mark; Javan, Arzhang Cyrus; Li, Yijia; Choudhary, Manish C; Deo, Rinki; Malvestutto, Carlos; Klekotka, Paul; Price, Karen; Nirula, Ajay; Fischer, William; Bala, Veenu; Ribeiro, Ruy M; Perelson, Alan S; Fletcher, Courtney V; Eron, Joseph J; Currier, Judith S; Hughes, Michael D; Smith, Davey M.
Afiliação
  • Chew KW; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, USA. kchew@mednet.ucla.edu.
  • Moser C; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Daar ES; Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Wohl DA; Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Li JZ; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Coombs RW; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
  • Ritz J; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Giganti M; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Javan AC; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Li Y; National Institutes of Health, Bethesda, MD, USA.
  • Choudhary MC; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Deo R; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Malvestutto C; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Klekotka P; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Price K; Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Nirula A; Eli Lilly and Company, San Diego, CA, USA.
  • Fischer W; Eli Lilly and Company, San Diego, CA, USA.
  • Bala V; Eli Lilly and Company, San Diego, CA, USA.
  • Ribeiro RM; Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Perelson AS; UNMC Center for Drug Discovery, University of Nebraska Medical Center, Omaha, NE, USA.
  • Fletcher CV; Clinical Pharmacology & Pharmacometrics, Jounce Therapeutics, Cambridge, MA, USA.
  • Eron JJ; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA.
  • Currier JS; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA.
  • Hughes MD; Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Smith DM; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, USA.
Nat Commun ; 14(1): 333, 2023 Jan 19.
Article em En | MEDLINE | ID: mdl-36658128
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos